Ads
related to: pharma
Search results
Earnings call: UroGen Pharma reports robust Q1 with promising pipeline
Investing.com· 24 hours agoUroGen Pharma ( NASDAQ : URGN) revealed a strong first quarter in 2024, with notable advancements in...
Earnings call: Innate Pharma reveals Q1 2024 results and pipeline progress
Investing.com· 24 hours agoInnate Pharma SA (OTC: IPHYF ) (IPHA) discussed its first quarter 2024 financial results and...
Pint Pharma announces ORLADEYO approval in Mexico for HAE prevention
Pharmaceutical Technology via Yahoo Finance· 20 hours agoPint Pharma has announced that the Federal Commission for Protection against Health Risks (COFEPRIS)...
Sun Pharma (SUN) Share Analysis - Investing.com India
Investing.com· 2 hours agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Lumos Pharma (LUMO) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 1 day agoLumos Pharma (NASDAQ:LUMO – Get Free Report) will be announcing its earnings results before the market opens on Wednesday, May 15th. Analysts expect the company to announce ...
Pharma exec testifies in Zantac trial that drug was safe and effective
Chicago Sun-Times· 1 day agoA pharmaceutical executive was grilled for hours about the safety of Zantac on Monday in a Cook...
Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market By Investing.com
Investing.com· 5 days agoVerona Pharma (NASDAQ:VRNA) has announced its first quarter 2024 financial results, highlighting the...
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions By Investing.com
Investing.com· 5 days agoRoyalty Pharma (RPRX) has reported a significant growth of 14% in Royalty Receipts, amounting to...
Cocrystal Pharma stock maintains price target, Outperform rating By Investing.com
Investing.com· 15 hours agoOn Tuesday, Noble Capital maintained its Outperform rating on Cocrystal Pharma (NASDAQ:COCP) with a...
Is Weakness In SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Stock A Sign That The Market Could be Wrong...
Simply Wall St. via Yahoo Finance· 7 days agoWith its stock down 5.5% over the past month, it is easy to disregard SCHOTT Pharma KGaA (ETR:1SXP)....